Medtronic unveils new systems combining continuous glucose monitoring and automated insulin delivery in a move to reduce daily management burdens and improve quality of life for diabetics.
Medtronic is pitching a simpler, more automated approach to diabetes care with two new systems aimed at reducing the day-to-day burden of managing blood sugar. In Milan, the company said its MiniMed 780G system with the Instinct sensor, alongside MiniMed Go with Instinct Go, is designed to bring continuous monitoring, automated insulin delivery and data handling into one workflow, with the stated goal of improving glucose control and quality of life.
The company says the MiniMed 780G is built to adapt insulin delivery automatically and can adjust to glucose readings every five minutes when paired with its sensor. Medtronic also says the system includes meal-detection features, personalised glucose targets and a larger reservoir and longer-wear infusion set to reduce how often users need to interact with the device. The Instinct sensor, developed by Abbott, is described as a discreet continuous glucose monitor with a 15-day wear time and no need for finger-prick checks.
Luigi Morgese, Medtronic Diabetes’ senior business lead, said the aim of these tools is to give time back to people living with type 1 diabetes, adding that more automated solutions should support better lives. Riccardo Candido, president of the Fondazione AMD, said sensor technology and automated insulin systems matter not only for glucose control and complication prevention, but also because they can improve freedom and independence in daily life. Paralympic champion Matteo Parenzan said the technology helps him manage diabetes with less anxiety and fewer decisions.
The company and diabetes specialists also stressed that technology does not replace medical care. Salvatore De Cosmo, president of AMD, said the relationship between doctor and patient remains essential, with digital tools adding more data and support to make treatment more personal. In that sense, the broader message of Medtronic’s announcement is less about gadgets than about a shift in diabetes care towards systems that aim to reduce constant effort and make everyday life feel less dominated by the condition.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
